Behringwerke Marburg Industrial Park with approximately 5,300 employees working in 16 companies is a biotechnology centre with innovative pharmaceutical companies. The industrial park on a total area of 67.4 hectares with 9.4 hectares of open space provides employment and development opportunities for a variety of different companies. These are managed by Pharmaserv GmbH, the sole operator of the industrial park, specialising in biotechnology and pharmaceutical production. The best-known companies are global pharmaceutical manufacturers CSL Behring, Behring GmbH, Novartis Vaccines and Diagnostics GmbH (a company of the GSK-Group), Novartis Influenza Vaccines Marburg GmbH and Siemens Healthcare Diagnostics Products GmbH.
Companies on the Industrial Park
Dynamic Industrial Park with Great Potential
The environment must be right. A key advantage for innovative pharmaceutical companies on Behringwerke Industrial Park. Established companies, start-ups and leading service companies take advantage of its existing infrastructure for research, production and sales or start work on the planning and construction of buildings and facilities together with the site operator – and thereby set the course for future and sustainable growth. Why not put your trust in the opportunities of an industrial park with excellent prospects.